Comparison of the effects on cardiovascular events between use of metformin and dipeptidyl peptidase-4 inhibitors as the first-line hypoglycaemic agents in Japanese patients with type 2 diabetes mellitus: a claims database analysis

OBJECTIVES: To compare the risk of cardiovascular events from the initiation of therapy between metformin and dipeptidyl peptidase-4 inhibitors (DPP-4i) as first-line therapy. DESIGN: Retrospective cohort study using two claims databases. SETTING: The MDV database (provided by Medical Data Vision) c...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishimura, Rimei, Takeshima, Tomomi, Iwasaki, Kosuke, Aoi, Sumiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919442/
https://www.ncbi.nlm.nih.gov/pubmed/35277396
http://dx.doi.org/10.1136/bmjopen-2020-045966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919442/
https://www.ncbi.nlm.nih.gov/pubmed/35277396
http://dx.doi.org/10.1136/bmjopen-2020-045966

Ejemplares similares